GEN Exclusives

More »

GEN News Highlights

More »
Nov 30, 2010

NewGene to Provide NimbleGen Sequence Capture Services in the U.K.

  • NewGene has become a certified service provider (CSP) for NimbleGen Sequence Capture arrays in the U.K. It will provide services related to SeqCap EZ arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences. In addition, it will process customer gDNA samples for genomic enrichment, using the complete NimbleGen Sequence Capture Array workflow optimized for 454 GS FLX Titanium Series sequencing.

    “The ability to couple NimbleGen Sequence Capture technology with our next-generation sequencing capabilities will provide significant scientific, technical, and economic benefits to our U.K, customers” says David Huntley, CEO at NewGene.

    NimbleGen Sequence Capture arrays enable users to produce targeted, sequencing-ready samples in the lab for use with next-generation sequencing instruments. Utilizing high-density, long-oligo NimbleGen arrays, either the whole human exome or the human genomic regions users specify are hybridized and eluted, ready for subsequent amplification and sequencing. The array-based process offers significant speed and scalability advantages over current PCR-based methods for targeted enrichment, according to Roche, NimbleGen's parent company.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »